Athanasios Bakalakos

543 total citations
17 papers, 190 citations indexed

About

Athanasios Bakalakos is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Epidemiology. According to data from OpenAlex, Athanasios Bakalakos has authored 17 papers receiving a total of 190 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cardiology and Cardiovascular Medicine, 7 papers in Molecular Biology and 3 papers in Epidemiology. Recurrent topics in Athanasios Bakalakos's work include Cardiomyopathy and Myosin Studies (6 papers), Cardiovascular Effects of Exercise (4 papers) and Viral Infections and Immunology Research (3 papers). Athanasios Bakalakos is often cited by papers focused on Cardiomyopathy and Myosin Studies (6 papers), Cardiovascular Effects of Exercise (4 papers) and Viral Infections and Immunology Research (3 papers). Athanasios Bakalakos collaborates with scholars based in United Kingdom, Italy and United States. Athanasios Bakalakos's co-authors include Nikolaos Karamichalakis, Konstantinos Vlachos, Michael Efremidis, Stamatis Georgopoulos, Antonios Sideris, Perry Elliott, Emanuele Monda, Κonstantinos P. Letsas, Giuseppe Limongelli and Aris Anastasakis and has published in prestigious journals such as European Heart Journal, Heart and Nature Reviews Cardiology.

In The Last Decade

Athanasios Bakalakos

15 papers receiving 184 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Athanasios Bakalakos United Kingdom 7 143 32 22 20 15 17 190
Luigi Falco Italy 7 86 0.6× 38 1.2× 19 0.9× 14 0.7× 13 0.9× 20 156
Jayakeerthi Y. Rao Belgium 9 256 1.8× 66 2.1× 21 1.0× 21 1.1× 10 0.7× 12 291
Vishal Vyas United Kingdom 7 143 1.0× 31 1.0× 19 0.9× 15 0.8× 20 1.3× 12 184
И. В. Жиров Russia 7 131 0.9× 55 1.7× 11 0.5× 28 1.4× 8 0.5× 93 205
Mio Ebato Japan 8 142 1.0× 15 0.5× 9 0.4× 23 1.1× 33 2.2× 44 163
Álvaro García‐Osuna Spain 7 80 0.6× 14 0.4× 29 1.3× 14 0.7× 25 1.7× 23 148
Miho Miyoshi Japan 8 93 0.7× 24 0.8× 27 1.2× 7 0.3× 10 0.7× 22 162
T. B. Pecherina Russia 7 75 0.5× 33 1.0× 9 0.4× 26 1.3× 12 0.8× 29 127
Raquel Campuzano Spain 7 92 0.6× 18 0.6× 13 0.6× 13 0.7× 22 1.5× 29 152
Nikolaos Karamichalakis Greece 8 276 1.9× 18 0.6× 6 0.3× 17 0.8× 17 1.1× 24 297

Countries citing papers authored by Athanasios Bakalakos

Since Specialization
Citations

This map shows the geographic impact of Athanasios Bakalakos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Athanasios Bakalakos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Athanasios Bakalakos more than expected).

Fields of papers citing papers by Athanasios Bakalakos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Athanasios Bakalakos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Athanasios Bakalakos. The network helps show where Athanasios Bakalakos may publish in the future.

Co-authorship network of co-authors of Athanasios Bakalakos

This figure shows the co-authorship network connecting the top 25 collaborators of Athanasios Bakalakos. A scholar is included among the top collaborators of Athanasios Bakalakos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Athanasios Bakalakos. Athanasios Bakalakos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Monda, Emanuele, et al.. (2026). Cardiovascular Morbidity and Mortality in Fabry Disease. Circulation Genomic and Precision Medicine. e005361–e005361.
2.
Bakalakos, Athanasios, Emanuele Monda, & Perry Elliott. (2025). Tailored therapeutics for cardiomyopathies. Nature Reviews Cardiology. 22(10). 814–831. 2 indexed citations
3.
Sengupta, Anshuman, Mohammed Akhtar, Massimiliano Lorenzini, et al.. (2025). Cardiomyopathy caused by mitochondrial DNA 4300A > G variant. European Heart Journal. 46(31). 3118–3121. 3 indexed citations
4.
Bakalakos, Athanasios, Emanuele Monda, & Perry Elliott. (2024). The Diagnostic and Therapeutic Implications of Phenocopies and Mimics of Hypertrophic Cardiomyopathy. Canadian Journal of Cardiology. 40(5). 754–765. 7 indexed citations
5.
Monda, Emanuele, Athanasios Bakalakos, Douglas Cannie, et al.. (2024). Prevalence of pathogenic variants in cardiomyopathy-associated genes in acute myocarditis: a systematic review and meta-analysis. European Heart Journal. 45(Supplement_1). 1 indexed citations
6.
Monda, Emanuele, Athanasios Bakalakos, Robin Lachmann, et al.. (2024). Incidence and risk factors for development of left ventricular hypertrophy in Fabry disease. Heart. 110(12). 846–853. 6 indexed citations
7.
Monda, Emanuele, Athanasios Bakalakos, Douglas Cannie, et al.. (2024). Prevalence of Pathogenic Variants in Cardiomyopathy-Associated Genes in Acute Myocarditis. JACC Heart Failure. 12(6). 1101–1111. 22 indexed citations
8.
Cannie, Douglas, Kush Patel, Alexandros Protonotarios, et al.. (2024). Prevalence of transthyretin cardiac amyloidosis in patients with high-degree AV block. Open Heart. 11(1). e002606–e002606. 3 indexed citations
9.
Gray, Belinda, Elijah R. Behr, Efstathios Papatheodorou, et al.. (2024). Influence of age and sex on the diagnostic yield of inherited cardiac conditions in sudden arrhythmic death syndrome decedents. European Journal of Preventive Cardiology. 33(3). 432–440. 2 indexed citations
10.
Monda, Emanuele, Athanasios Bakalakos, Marta Rubino, et al.. (2023). Targeted Therapies in Pediatric and Adult Patients With Hypertrophic Heart Disease: From Molecular Pathophysiology to Personalized Medicine. Circulation Heart Failure. 16(8). e010687–e010687. 19 indexed citations
11.
Monda, Emanuele, Athanasios Bakalakos, Petros Syrris, et al.. (2023). Cardiovascular involvement in later-onset malonyl-CoA decarboxylase deficiency: Case studies and literature review. European Journal of Medical Genetics. 66(12). 104885–104885. 1 indexed citations
12.
Monda, Emanuele, Francesca Graziani, Marta Rubino, et al.. (2023). Impact of GLA Variant Classification on the Estimated Prevalence of Fabry Disease: A Systematic Review and Meta-Analysis of Screening Studies. Circulation Genomic and Precision Medicine. 16(6). e004252–e004252. 8 indexed citations
13.
Cannie, Douglas, Kush Patel, Leon Menezes, et al.. (2023). 9 Prevalence of transthyretin cardiac amyloidosis in patients with high degree AV block. A11–A12. 1 indexed citations
14.
Parry‐Williams, Gemma, Daniel R. Obaid, Ioannis Vlahos, et al.. (2021). 183 Low-grade hypertension and coronary atherosclerosis in male master endurance athletes. A142–A143.
15.
Bakalakos, Athanasios, et al.. (2018). Current perspectives on the diagnosis and management of dilated cardiomyopathy Beyond heart failure: a Cardiomyopathy Clinic Doctor's point of view. Hellenic Journal of Cardiology. 59(5). 254–261. 19 indexed citations
16.
Vlachos, Konstantinos, Panagiotis Korantzopoulos, Tong Liu, et al.. (2016). Prediction of atrial fibrillation development and progression: Current perspectives. World Journal of Cardiology. 8(3). 267–267. 42 indexed citations
17.
Letsas, Κonstantinos P., Nikolaos Karamichalakis, Konstantinos Vlachos, et al.. (2015). Managing atrial fibrillation in the very elderly patient: challenges and solutions. Vascular Health and Risk Management. 11. 555–555. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Luigi Falco Breakdown of academic impact, for papers by Jayakeerthi Y. Rao Breakdown of academic impact, for papers by Vishal Vyas Breakdown of academic impact, for papers by И. В. Жиров Breakdown of academic impact, for papers by Mio Ebato Breakdown of academic impact, for papers by Álvaro García‐Osuna Breakdown of academic impact, for papers by Miho Miyoshi Breakdown of academic impact, for papers by T. B. Pecherina Breakdown of academic impact, for papers by Raquel Campuzano Breakdown of academic impact, for papers by Nikolaos Karamichalakis
Rankless by CCL
2026